A joint article by the team at Duke Eye Center and Liberty Vision Founder Dr. Paul Finger highlights the effectiveness of the Y-90 Disc in treating squamous cell carcinoma: Read more Yttrium-90 (90Y) Brachytherapy for Squamous Carcinoma: Treatment of the Conjunctiva,...
In the 2024 copy of VISION magazine, Duke Eye Center features the Liberty Vision Y-90 Disc procedure that the center has recently started performing. Under the guidance of Dr. Miguel Materin, MD, Division Chief of Duke’s newly formed Division of Ocular Oncology,...
Liberty Vision is pleased to announce the world’s first publication on LV Y-90 Disc brachytherapy! This new technology was initially employed to treat patients with iris, and iridociliary melanomas as well as ocular surface malignant squamous carcinoma. However,...
We are excited to announce that the results from a procedure utilizing our iWand P and LV Y-90 Disc to treat choroidal melanoma will be presented as an abstract at The Retina Society 55th Annual meeting in November titled The 4-Minute Plaque: High Dose Rate (HDR)...
Liberty Vision Corporation is pleased to announce the first patients have been treated utilizing the LV Y-90 Disc and iWand® A! Initial experience will be presented in San Antonio, Texas on October 26th, 2022 at this year’s ASTRO (American Society for Radiation...
